off
Sanofi lands EC approval for its cholesterol-busting Praluent
Regeneron Pharmaceuticals and Sanofi announced Monday that Praluent has received approval from the European Commission (EC) as treatment for bad cholesterol in adults diagnosed with hypercholesterolemia. Based on results, Praluent offered dramatic reductions in LDL-cholesterol...
Posted On Sep 29 2015
